Drug Shortage Report for MYLAN-RIVASTIGMINE PATCH 10
| Report ID | 83413 |
| Drug Identification Number | 02423421 |
| Brand name | MYLAN-RIVASTIGMINE PATCH 10 |
| Common or Proper name | RIVASTIGMINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVASTIGMINE |
| Strength(s) | 18MG |
| Dosage form(s) | PATCH |
| Route of administration | TRANSDERMAL |
| Packaging size | 30 PATCHES |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-06-04 |
| Actual start date | 2019-06-04 |
| Estimated end date | 2019-07-26 |
| Actual end date | 2019-07-29 |
| Shortage status | Resolved |
| Updated date | 2019-07-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-05-08 | French | Compare |
| v1 | 2019-05-08 | English | Compare |